Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer
Clinical trial NCT05705921 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05705921
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-26
- Primary completion
- 2032-01-01
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.